Literature DB >> 11952786

The fate of newly synthesized V-ATPase accessory subunit Ac45 in the secretory pathway.

Vincent Th G Schoonderwoert1, Eric J R Jansen, Gerard J M Martens.   

Abstract

The vacuolar H+-ATPase (V-ATPase) is a multimeric enzyme complex that acidifies organelles of the vacuolar system in eukaryotic cells. Proteins that interact with the V-ATPase may play an important role in controlling the intracellular localization and activity of the proton pump. The neuroendocrine-enriched V-ATPase accessory subunit Ac45 may represent such a protein as it has been shown to interact with the membrane sector of the V-ATPase in only a subset of organelles. Here, we examined the fate of newly synthesized Ac45 in the secretory pathway of a neuroendocrine cell. A major portion of intact approximately 46-kDa Ac45 was found to be N-linked glycosylated to approximately 62 kDa and a minor fraction to approximately 64 kDa. Trimming of the N-linked glycans gave rise to glycosylated Ac45-forms of approximately 61 and approximately 63 kDa that are cleaved to a C-terminal fragment of 42-44 kDa (the deglycosylated form is approximately 23 kDa), and a previously not detected approximately 22-kDa N-terminal cleavage fragment (the deglycosylated form is approximately 20 kDa). Degradation of the N-terminal fragment is rapid, does not occur in lysosomes and is inhibited by brefeldin A. Both the N- and C-terminal fragment pass the medial Golgi, as they become partially endoglycosidase H resistant. The Ac45 cleavage event is a relatively slow process (half-life of intact Ac45 is 4-6 h) and takes place in the early secretory pathway, as it is not affected by brefeldin A and monensin. Tunicamycin inhibited N-linked glycosylation of Ac45 and interfered with the cleavage process, suggesting that Ac45 needs proper folding for the cleavage to occur. Together, our results indicate that Ac45 folding and cleavage occur slowly and early in the secretory pathway, and that the cleavage event may be linked to V-ATPase activation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11952786     DOI: 10.1046/j.1432-1033.2002.02831.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  7 in total

1.  V-ATPase subunit ATP6AP1 (Ac45) regulates osteoclast differentiation, extracellular acidification, lysosomal trafficking, and protease exocytosis in osteoclast-mediated bone resorption.

Authors:  De-Qin Yang; Shengmei Feng; Wei Chen; Haibo Zhao; Christie Paulson; Yi-Ping Li
Journal:  J Bone Miner Res       Date:  2012-08       Impact factor: 6.741

2.  Identification of domains within the V-ATPase accessory subunit Ac45 involved in V-ATPase transport and Ca2+-dependent exocytosis.

Authors:  Eric J R Jansen; Nick H M van Bakel; Nikkie F M Olde Loohuis; Theo G M Hafmans; Tim Arentsen; Anthon J M Coenen; Wim J J M Scheenen; Gerard J M Martens
Journal:  J Biol Chem       Date:  2012-06-26       Impact factor: 5.157

3.  V-ATPase-mediated granular acidification is regulated by the V-ATPase accessory subunit Ac45 in POMC-producing cells.

Authors:  Eric J R Jansen; Theo G M Hafmans; Gerard J M Martens
Journal:  Mol Biol Cell       Date:  2010-08-11       Impact factor: 4.138

4.  The V-ATPase accessory protein Atp6ap1b mediates dorsal forerunner cell proliferation and left-right asymmetry in zebrafish.

Authors:  Jason J Gokey; Agnik Dasgupta; Jeffrey D Amack
Journal:  Dev Biol       Date:  2015-08-05       Impact factor: 3.582

5.  ATP6AP1 deficiency causes an immunodeficiency with hepatopathy, cognitive impairment and abnormal protein glycosylation.

Authors:  Eric J R Jansen; Sharita Timal; Margret Ryan; Angel Ashikov; Monique van Scherpenzeel; Laurie A Graham; Hanna Mandel; Alexander Hoischen; Theodore C Iancu; Kimiyo Raymond; Gerry Steenbergen; Christian Gilissen; Karin Huijben; Nick H M van Bakel; Yusuke Maeda; Richard J Rodenburg; Maciej Adamowicz; Ellen Crushell; Hans Koenen; Darius Adams; Julia Vodopiutz; Susanne Greber-Platzer; Thomas Müller; Gregor Dueckers; Eva Morava; Jolanta Sykut-Cegielska; Gerard J M Martens; Ron A Wevers; Tim Niehues; Martijn A Huynen; Joris A Veltman; Tom H Stevens; Dirk J Lefeber
Journal:  Nat Commun       Date:  2016-05-27       Impact factor: 14.919

6.  SARS-CoV-2 non-structural protein 6 triggers NLRP3-dependent pyroptosis by targeting ATP6AP1.

Authors:  Xiao Sun; Yingzhi Liu; Ziheng Huang; Wenye Xu; Wei Hu; Lina Yi; Zhe Liu; Hung Chan; Judeng Zeng; Xiaodong Liu; Huarong Chen; Jun Yu; Francis Ka Leung Chan; Siew Chien Ng; Sunny Hei Wong; Maggie Haitian Wang; Tony Gin; Gavin Matthew Joynt; David Shu Cheong Hui; Xuan Zou; Yuelong Shu; Christopher Hon Ki Cheng; Shisong Fang; Huanle Luo; Jing Lu; Matthew Tak Vai Chan; Lin Zhang; William Ka Kei Wu
Journal:  Cell Death Differ       Date:  2022-01-08       Impact factor: 12.067

7.  ATP6AP2 functions as a V-ATPase assembly factor in the endoplasmic reticulum.

Authors:  Maria Clara Guida; Tobias Hermle; Laurie A Graham; Virginie Hauser; Margret Ryan; Tom H Stevens; Matias Simons
Journal:  Mol Biol Cell       Date:  2018-07-11       Impact factor: 4.138

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.